The SRC VB VECTOR specialists made a working visit to the Center for Integration Medicine and Innovative Technology, Massachusetts Institute of Technology (Boston, USA).
For the first time visit had been organized under the auspices of CIMIT and the BII Program (US Department of State). Main goal of visit to the Center for Integration of Medicine and Innovative Technology was training in research methods of molecular mechanisms of the immunomodulators’ action (including the “Ridostin” drug created at the Research and Design Institute of Biologically Active Substances, SRC VB VECTOR).
The SRC VB VECTOR specialists made a working visit to the Center for Integration Medicine and Innovative Technology, Massachusetts Institute of Technology (Boston, USA).
For the first time visit had been organized under the auspices of CIMIT and the BII Program (US Department of State). Main goal of visit to the Center for Integration of Medicine and Innovative Technology was training in research methods of molecular mechanisms of the immunomodulators’ action (including the “Ridostin” drug created at the Research and Design Institute of Biologically Active Substances, SRC VB VECTOR).
“Ridostin” is based on the double-helical RNA playing a big part today in creating a new class of drugs for medicine and diagnostic systems.
Since November 2004 the project in researching molecular mechanisms of the double-helical RNA action in mammal cells has been accomplishing at the SRC VB VECTOR in association with International Science-Technology Center and BioIndustry Initiative Program. Delegation to Boston (of 3 persons) included the project participants – employees of the Center VECTOR and the Institute of Chemical Biology and Basic Medicine, SB RAS.
Visit to Boston opened a complex of joint Russian-American researches of molecular mechanisms of the “Ridostin” and other immunomodulators’ action.
New methods that will further enlarge the “Ridostin” field of application were mastered as a result of the collaboration with the Center for Integration of Medicine and Innovative Technology.